The standardized uptake value calculated from (111)In-ibritumomab tiuxetan single-photon emission computed tomography/computed tomography is a useful predictor of the clinical response in patients treated by (90)Y- ibritumomab tiuxetan therapy

(90)Y-Ibritumomab tiuxetan (IT) therapy is a radioimmunotherapy for indolent B-cell lymphoma. Several predictors of insufficient therapeutic effects have been reported. We performed a retrospective study at a single institute to investigate whether (111)In SPECT/CT can predict the therapeutic effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Kume, Ayaka, Toriihara, Akira, Shimizu, Ryo, Harata, Naoki, Isogai, Jun, Tanaka, Hiroaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JSLRT 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053570/
https://www.ncbi.nlm.nih.gov/pubmed/33551439
http://dx.doi.org/10.3960/jslrt.20055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053570/
https://www.ncbi.nlm.nih.gov/pubmed/33551439
http://dx.doi.org/10.3960/jslrt.20055

Ejemplares similares